Immunological Medicines for Pigs
Immunological veterinary medicinal products, including vaccines, are authorised for pigs.
Name
|
Description
|
Marketing Authorisation Holder
|
License Number
|
License Date
|
Animal
|
Further Information
|
Suivac APP
|
Actinobacillus Pleuropneumonie
|
ChemVet DK A/S, Dänemark
|
PEI.V.11863.01.1 |
01.09.2016 |
Schwein |
PharmNet.Bund
|
Coglapix
|
Actinobazillus pleuropneumonie
|
Ceva Tiergesundheit GmbH
|
PEI.V.11731.01.1 |
12.10.2015 |
Schwein |
PharmNet.Bund
|
Porcilis APP
|
Actinobazillus Pleuropneumonie
|
Intervet Deutschland GmbH
|
210a/94 |
02.01.1996 |
Schwein |
PharmNet.Bund
|
Suigen APP 2, 9, 11
|
Actinobazillus pleuropneumonie
|
VIRBAC, Frankreich
|
PEI.V.12153.01.1 |
12.06.2023 |
Schwein |
|
Porcilis Begonia I.D.A.L.
|
Aujeszky'sche Krankheit
|
Intervet Deutschland GmbH
|
550a/93 |
03.01.1995 |
Schwein |
PharmNet.Bund
|
Ingelvac Aujeszky MLV plus
|
Aujeszky'sche Krankheit
|
Boehringer Ingelheim Vetmedica GmbH
|
320a/93 |
19.07.1997 |
Schwein |
PharmNet.Bund
|
Porcilis Begonia Diluvac
|
Aujeszky'sche Krankheit
|
Intervet Deutschland GmbH
|
81a/91 |
20.09.2004 |
Schwein |
PharmNet.Bund
|
Porcilis Begonia Unisolve
|
Aujeszky'sche Krankheit
|
Intervet Deutschland GmbH
|
53a/95 |
02.05.1995 |
Schwein |
PharmNet.Bund
|
Suvaxyn Circo
|
Circovirus-Infektion
|
Zoetis Belgium S.A., Belgien
|
EU/2/17/223/001-006 |
07.02.2018 |
Schwein |
EPAR: Suvaxyn Circo
|
Circovac
|
Circovirus-Infektion
|
CEVA-PHYLAXIA Co. Ltd., Ungarn
|
EU/2/07/075/001-010 |
25.06.2007 |
Ferkel, Zuchtsau |
EPAR: Circovac
|
CircoMax
|
Circovirus-Infektion
|
Zoetis Belgium, S.A., Belgien
|
EU/2/21/281 |
11.01.2022 |
Schwein |
|
Porcilis PCV
|
Circovirus-Infektion
|
Intervet International B.V., Niederlande
|
EU/2/08/091/001-010 |
12.01.2009 |
Schwein |
EPAR: Porcilis PCV
|
Ingelvac CircoFLEX
|
Circovirus-Infektion
|
Boehringer Ingelheim Vetmedica GmbH
|
EU/2/07/079/001-004 |
13.02.2008 |
Schwein |
EPAR: Ingelvac CircoFLEX
|
Porcilis PCV ID
|
Circovirus-Infektion
|
Intervet International B.V., Niederlande
|
EU/2/15/187/001-004 |
28.08.2015 |
Schwein |
EPAR: Porcilis PCV ID
|
Suvaxyn Circo + MH RTU
|
Circovirus-Infektion, Enzootische Pneumonie
|
Zoetis Belgium S.A., Belgien
|
EU/2/15/190/001-006 |
06.11.2015 |
Schwein |
EPAR: Suvaxyn-circo-mh-rtu
|
Porcilis PCV M Hyo
|
Circovirus-Infektion, Enzootische Pneumonie
|
Intervet International B.V., Niederlande
|
EU/2/14/175/001-010 |
07.11.2014 |
Schwein |
EPAR: Porcilis PCV M Hyo
|
Porcilis PCV M Hyo ID
|
Circovirus-Infektion, Enzootische Pneumonie
|
Intervet International B.V., Niederlande
|
EU/2/24/319 |
02.09.2024 |
Schwein |
EPAR: Porcilis PCV M Hyo ID
|
Cirbloc M Hyo
|
Circovirus-Infektion, Enzootische Pneumonie
|
Ceva-Phylaxia Co. Ltd., Ungarn
|
EU/2/24/322 |
25.10.2024 |
Schwein |
EPAR: Cirbloc M Hyo
|
CircoMax Myco
|
Circovirus-Infektion, Mykoplasmen-Infektion
|
Zoetis Belgium S.A., Belgien
|
EU/2/20/264/001-006 |
09.12.2020 |
Schwein |
EPAR: CircoMax Myco
|
MHYOSPHERE PCV ID
|
Circovirus-Infektion, Mykoplasmen-Infektion
|
Laboratorios Hipra, S.A., Spanien
|
EU/2/20/259 |
18.09.2020 |
Schwein |
EPAR: MHYOSPHERE PCV ID
|
Suiseng Diff/A
|
Clostridien-Infektion (Clostridioides difficile, Clostridium perfringens)
|
Laboratorios Hipra, S.A., Spanien
|
EU/2/21/278 |
07.12.2021 |
Schwein |
EPAR: Suiseng Diff/A
|
Coliprotec F4/F18
|
E. coli-Enteritiden
|
Elanco GmbH
|
EU/2/16/202/001-003 |
09.01.2017 |
Schwein |
EPAR: Coliprotec F4/F18
|
Porcilis Porcoli Diluvac Forte
|
E. coli-Ferkelenteritis
|
Intervet International BV, Niederlande
|
EU/2/96/001/003-008 |
22.05.2002 |
Schwein |
EPAR: Porcilis Porcoli Diluvac Forte
|
Gletvax 6
|
E. coli-Infektion,
Nekrotisierende Enteritis der Ferkel
|
Zoetis Deutschland GmbH
|
254a/94 |
30.06.1998 |
Schwein |
PharmNet.Bund
|
Porcilis ColiClos
|
E. coli-Infektion,
Clostridien-Infektion
|
Intervet International BV, Niederlande
|
EU/2/12/141/001-009 |
17.06.2012 |
Schwein |
EPAR: Porcilis ColiClos
|
Disclaimer
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 530 in BAnz AT 16.06.2025 B4.
Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.